126 related articles for article (PubMed ID: 7492785)
21. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
Yoo EK; Cassin M; Lessin SR; Rook AH
J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
[TBL] [Abstract][Full Text] [Related]
22. Detection of clonally rearranged T-cell-receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis.
Witzens M; Möhler T; Willhauck M; Scheibenbogen C; Lee KH; Keilholz U
Ann Hematol; 1997 Mar; 74(3):123-30. PubMed ID: 9111425
[TBL] [Abstract][Full Text] [Related]
23. Routine diagnosis of large granular lymphocytic leukaemia by Southern blot and polymerase chain reaction analysis of clonal T cell receptor gene rearrangement.
Ryan DK; Alexander HD; Morris TC
Mol Pathol; 1997 Apr; 50(2):77-81. PubMed ID: 9231154
[TBL] [Abstract][Full Text] [Related]
24. Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome.
Kono DH; Baccala R; Balderas RS; Kovac SJ; Heald PW; Edelson RL; Theofilopoulos AN
Am J Pathol; 1992 Apr; 140(4):823-30. PubMed ID: 1562047
[TBL] [Abstract][Full Text] [Related]
25. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.
Kelemen K; Guitart J; Kuzel TM; Goolsby CL; Peterson LC
Am J Clin Pathol; 2008 Jan; 129(1):146-56. PubMed ID: 18089499
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping.
Bakels V; van Oostveen JW; Preesman AH; Meijer CJ; Willemze R
J Clin Pathol; 1998 Feb; 51(2):154-8. PubMed ID: 9602691
[TBL] [Abstract][Full Text] [Related]
27. [Peripheral blood Sézary cells and the diagnosis of Sézary syndrome].
Tessier-Marteau A; Le Corre Y; Gérard J; Avenel-Audran M; Geneviève F; Verret JL; Zandecki M
Ann Biol Clin (Paris); 2008; 66(4):447-53. PubMed ID: 18725348
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone.
Trotter MJ; Whittaker SJ; Orchard GE; Smith NP
J Cutan Pathol; 1997 May; 24(5):286-91. PubMed ID: 9194581
[TBL] [Abstract][Full Text] [Related]
29. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
Nagler AR; Samimi S; Schaffer A; Vittorio CC; Kim EJ; Rook AH
J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue.
Wang S; Li N; Heald P; Fisk JM; Fadare O; Howe JG; McNiff JM; Smith BR
Am J Clin Pathol; 2004 Nov; 122(5):774-82. PubMed ID: 15491974
[TBL] [Abstract][Full Text] [Related]
33. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
[TBL] [Abstract][Full Text] [Related]
34. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma.
Muche JM; Lukowsky A; Asadullah K; Gellrich S; Sterry W
Blood; 1997 Aug; 90(4):1636-42. PubMed ID: 9269783
[TBL] [Abstract][Full Text] [Related]
35. Improved polymerase chain reaction detection of clonally rearranged T-cell receptor beta chain genes.
Zemlin M; Hummel M; Anagnostopoulos I; Stein H
Diagn Mol Pathol; 1998 Jun; 7(3):138-45. PubMed ID: 9836068
[TBL] [Abstract][Full Text] [Related]
36. T-cell receptor gene analysis in the diagnosis of Sézary syndrome.
Russell-Jones R; Whittaker S
J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):254-9. PubMed ID: 10426897
[TBL] [Abstract][Full Text] [Related]
37. The Sézary syndrome: hematologic criteria.
Vonderheid EC; Bernengo MG
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1367-89, viii. PubMed ID: 14710890
[TBL] [Abstract][Full Text] [Related]
38. Analyses of T-cell receptor beta-chain genes by Southern blotting in known and suspected cutaneous T-cell lymphoma. A study of 67 samples from 32 patients.
Wolff-Sneedorff A; Ralfkiaer E; Thomsen K; Vejlsgaard GL
Clin Exp Dermatol; 1995 Mar; 20(2):115-22. PubMed ID: 8565244
[TBL] [Abstract][Full Text] [Related]
39. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
[TBL] [Abstract][Full Text] [Related]
40. High-resolution analysis of gene rearrangements in lymphoid malignancies.
Ayling JF; Iland HJ
Pathology; 1999 Aug; 31(3):252-6. PubMed ID: 10503272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
